Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Cavallari LH, Lee CR, Beitelshees AL, Cooper-DeHoff RM, Duarte JD, Voora D, Kimmel SE, McDonough CW, Gong Y, Dave CV, Pratt VM, Alestock TD, Anderson RD, Alsip J, Ardati AK, Brott BC, Brown L, Chumnumwat S, Clare-Salzler MJ, Coons JC, Denny JC, Dillon C, Elsey AR, Hamadeh IS, Harada S, Hillegass WB, Hines L, Horenstein RB, Howell LA, Jeng LJB, Kelemen MD, Lee YM, Magvanjav O, Montasser M, Nelson DR, Nutescu EA, Nwaba DC, Pakyz RE, Palmer K, Peterson JF, Pollin TI, Quinn AH, Robinson SW, Schub J, Skaar TC, Smith DM, Sriramoju VB, Starostik P, Stys TP, Stevenson JM, Varunok N, Vesely MR, Wake DT, Weck KE, Weitzel KW, Wilke RA, Willig J, Zhao RY, Kreutz RP, Stouffer GA, Empey PE, Limdi NA, Shuldiner AR, Winterstein AG, Johnson JA; IGNITE Network.

JACC Cardiovasc Interv. 2017 Oct 25. pii: S1936-8798(17)31499-1. doi: 10.1016/j.jcin.2017.07.022. [Epub ahead of print]

PMID:
29102571
2.

The need for sex-specific precision biomarkers for antiplatelet therapies.

Friede K, Voora D.

Future Cardiol. 2017 Aug 23. doi: 10.2217/fca-2017-0043. [Epub ahead of print] No abstract available.

PMID:
28832186
3.

The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.

Musunuru K, Ingelsson E, Fornage M, Liu P, Murphy AM, Newby LK, Newton-Cheh C, Perez MV, Voora D, Woo D; American Heart Association Committee on Molecular Determinants of Cardiovascular Health of the Council on Functional Genomics and Translational Biology and Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; and Stroke Council.

Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e000037. doi: 10.1161/HCG.0000000000000037. Review.

PMID:
28760750
4.

Transcription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events: Differential Effects of RUNX1 Variants.

Mao G, Songdej N, Voora D, Goldfinger LE, Del Carpio-Cano FE, Myers RA, Rao AK.

Circulation. 2017 Sep 5;136(10):927-939. doi: 10.1161/CIRCULATIONAHA.116.023711. Epub 2017 Jul 4.

PMID:
28676520
5.

Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.

Haga SB, Moaddeb J, Mills R, Voora D.

Pharmacogenomics. 2017 Mar;18(4):327-335. doi: 10.2217/pgs-2016-0175. Epub 2017 Feb 22.

PMID:
28244804
6.

An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.

Voora D, Coles A, Lee KL, Hoffmann U, Wingrove JA, Rhees B, Huang L, Daniels SE, Monane M, Rosenberg S, Shah SH, Kraus WE, Ginsburg GS, Douglas PS.

Am Heart J. 2017 Feb;184:133-140. doi: 10.1016/j.ahj.2016.11.004. Epub 2016 Nov 15.

7.

Circulating extracellular vesicles containing miRNAs may have utility as early biomarkers for cardiac injury.

Doran B, Voora D.

Ann Transl Med. 2016 Oct;4(Suppl 1):S60. No abstract available.

8.

Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.

Friede K, Li J, Voora D.

Clin Chem. 2017 Jan;63(1):177-185. doi: 10.1373/clinchem.2016.255232. Epub 2016 Nov 18. Review.

PMID:
27864383
9.

Rationale and design of the SLCO1B1 genotype guided statin therapy trial.

Singh K, Peyser B, Trujillo G, Milazzo N, Savard D, Haga SB, Musty M, Voora D.

Pharmacogenomics. 2016 Nov 3. [Epub ahead of print] No abstract available.

PMID:
27807988
10.

Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer.

Voora D, Rao AK, Jalagadugula GS, Myers R, Harris E, Ortel TL, Ginsburg GS.

EBioMedicine. 2016 Sep;11:157-164. doi: 10.1016/j.ebiom.2016.08.021. Epub 2016 Aug 14.

11.

Pharmacometabolomics Meets Genetics: A "Natural" Clinical Trial of Statin Effects.

Voora D, Shah SH.

J Am Coll Cardiol. 2016 Mar 15;67(10):1211-1213. doi: 10.1016/j.jacc.2016.01.022. No abstract available.

12.

Genome-wide association study on progression of carotid artery intima media thickness over 10 years in a Chinese cohort.

Xie G, Myint PK, Voora D, Laskowitz DT, Shi P, Ren F, Wang H, Yang Y, Huo Y, Gao W, Wu Y.

Atherosclerosis. 2015 Nov;243(1):30-7. doi: 10.1016/j.atherosclerosis.2015.08.034. Epub 2015 Sep 5.

PMID:
26343869
13.

Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction.

Rose JJ, Voora D, Cyr DD, Lucas JE, Zaas AK, Woods CW, Newby LK, Kraus WE, Ginsburg GS.

PLoS One. 2015 Jul 20;10(7):e0132259. doi: 10.1371/journal.pone.0132259. eCollection 2015.

14.

Gene Expression Signatures and the Spectrum of Coronary Artery Disease.

Friede KA, Ginsburg GS, Voora D.

J Cardiovasc Transl Res. 2015 Aug;8(6):339-52. doi: 10.1007/s12265-015-9640-6. Epub 2015 Jun 19. Review.

PMID:
26089288
15.

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.

Varenhorst C, Eriksson N, Johansson Å, Barratt BJ, Hagström E, Åkerblom A, Syvänen AC, Becker RC, James SK, Katus HA, Husted S, Steg PG, Siegbahn A, Voora D, Teng R, Storey RF, Wallentin L; PLATO Investigators.

Eur Heart J. 2015 Aug 1;36(29):1901-12. doi: 10.1093/eurheartj/ehv116. Epub 2015 May 2.

PMID:
25935875
16.

SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.

Li JH, Suchindran S, Shah SH, Kraus WE, Ginsburg GS, Voora D.

Pharmacogenomics. 2015;16(5):449-58. doi: 10.2217/pgs.15.2.

17.

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics.

Beitelshees AL, Voora D, Lewis JP.

Pharmgenomics Pers Med. 2015 Feb 9;8:43-61. doi: 10.2147/PGPM.S52900. eCollection 2015. Review.

18.

Module-based association analysis for omics data with network structure.

Wang Z, Maity A, Hsiao CK, Voora D, Kaddurah-Daouk R, Tzeng JY.

PLoS One. 2015 Mar 30;10(3):e0122309. doi: 10.1371/journal.pone.0122309. eCollection 2015.

19.

Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients.

Li JH, Joy SV, Haga SB, Orlando LA, Kraus WE, Ginsburg GS, Voora D.

J Pers Med. 2014 Mar 27;4(2):147-62. doi: 10.3390/jpm4020147.

20.

Expression quantitative trait locus analysis identifies novel genes for statin myopathy.

Voora D.

Circ Cardiovasc Genet. 2014 Apr;7(2):220-1. doi: 10.1161/CIRCGENETICS.114.000611. No abstract available.

Supplemental Content

Loading ...
Support Center